Neuronetrix, a leader in advanced neurodiagnostic technology, has developed COGNISION™, a breakthrough cognitive testing and analysis system that will be used by both physicians and scientists to identify and evaluate Alzheimer’s disease, ADHD, and other cognitive disorders in an easy and noninvasive way.

The COGNISION™ System is currently being used in academic, clinical, and pharmaceutical studies around the world for a range of neurological disorders.  The COGNISION™ System has even been used by the US Army in Afghanistan to evaluate the immediate cognitive effects of blast injuries sustained by front-line soldiers.

Beyond cognitive/clinical research and pharmaceutical trials, the primary market for the COGNISION™ System is with clinicians for the evaluation of Alzheimer’s disease, ADHD, and other disorders which have cognitive deficits as their main clinical presentation.

See Also:


   Management Team